versus

Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children

Condition:   AsthmaInterventions:   Drug: Ipratropium bromide;   Drug: Placebo;   Drug: SalbutamolSponsor:   Boehringer IngelheimTerminated – verified September 2014 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Study to Evaluate is ECV Success is Improved and the Side Effects Reduced With the Use of IV NTGL Versus Terbutaline

Condition:   External Cephalic VersionInterventions:   Drug: Intravenous Terbutaline;   Drug: Intravenous NitroglycerineSponsors:   Mount Sinai School of Medicine;   Yaakov BeilinNot yet recruiting – verified April 2014 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

A Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in High Risk Patients

Condition:   Post-ERCP Acute PancreatitisInterventions:   Drug: Rectal Indomethacin;   Drug: EpinephrineSponsors:   Johns Hopkins University;   American Society for Gastrointestinal Endoscopy;   Asian Institute of Gastroenterology, India;   Postgraduate Institute of Medical Education and Research;   Apollo Gleneagles Hospitals, IndiaNot yet recruiting – verified April 2014 View full post on ClinicalTrials.gov: asthma | received in the last…

Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.

Related Articles Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. Cochrane Database Syst Rev. 2014 Jan 24;1:CD003137 Authors: Chauhan BF, Ducharme FM Abstract BACKGROUND: Asthma patients who continue to experience symptoms despite taking regular inhaled corticosteroids…

Efficacy and Safety of Activation Energy Serum (AES) Versus Placebo in Persistent Asthma.

Condition:   Mild to Moderate Persistent AsthmaIntervention:   Dietary Supplement: Activation Energy SerumSponsors:   California Allergy and Asthma Medical Group, Inc.;   California Allergy and Asthma Medical Group, Inc.Not yet recruiting – verified September 2013 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Clinician Versus Community Health Worker Support to Help Patients Control Chronic Disease

Conditions:   Obesity;   Diabetes;   Hypertension;   Asthma/COPD With Tobacco DependenceInterventions:   Behavioral: CHW Goal Support;   Behavioral: Clinician Goal SupportSponsors:   University of Pennsylvania;   University of PennsylvaniaRecruiting – verified July 2013 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Years Old

Condition:   AsthmaInterventions:   Drug: CHF1535 pMDI + AC Plus;   Drug: BDP + AC Plus;   Drug: Formoterol + AC PlusSponsors:   Chiesi Farmaceutici S.p.A.;   Chiesi Farmaceutici S.p.A.Completed – verified May 2013 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

CLINICAL PHARMACOLOGY STUDY OF A FIXED COMBINATION OF BECLOMETHASONE DIPROPIONATE 50µg PLUS FORMOTEROL FUMARATE 6 µg VERSUS THE FREE COMBINATION OF BECLOMETHASONE HFA pMDI AND FORMOTEROL HFA pMDI AVAILABLE ON THE MARKET USING THE AEROCHAMBER PLUS™ SPACER DEVICE IN ASTHMATIC CHILDREN

Condition:   AsthmaInterventions:   Drug: CHF1535 pMDI + AC Plus;   Drug: BDP and Formoterol + AC PlusSponsors:   Chiesi Farmaceutici S.p.A.;   Chiesi Farmaceutici S.p.A.Completed – verified April 2013 View full post on ClinicalTrials.gov: asthma | received in the last 14 days